Paul Takam Kamga

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Cancers

Cancer research

International journal of molecular sciences

Université Versailles Saint-Quentin-en-Yvelines

University of Verona, Italy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université Versailles Saint-Quentin-en-Yvelines Nov 01 2018

France

Research Associate

Académie de Versailles Sep 01 2017

France

Lecturer

University of Verona, Italy May 01 2016 - Sep 01 2017

Italy

Post-Doctoral Fellow :: Department of Medicine

University of British Columbia Mar 01 2012 - Aug 31 2012

Canada

Graduate Research Assistant :: Life Science Institue,

Université de Poitiers Oct 01 2011 - Feb 26 2012

France

Intern :: Pôle Professionnel Biologie Santé

Université de Poitiers Apr 01 2010 - Jun 30 2011

France

Graduate Research Assistant :: Pole Biologie Santé

Ministry of Health, Cameroun Jul 01 2007 - Aug 31 2009

Cameroon

Undergraduate Clinical Research assistant :: Laquintinie and Nylon Hospitals

Education History

University of Verona, Italy Jan 01 2013 - May 01 2016

Italy

PHD :: Department of Medicine

Université de Poitiers UFR Sciences Fondamentales et Appliquées Sep 01 2009 - Jul 01 2011

France

MSC

Universite de Douala Faculte des Sciences Oct 01 2007 - Aug 31 2008

Cameroon

BSC

Publications

Giada Dal Collo, Paul Takam Kamga
Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy. Cancers 15 (18) (2023)
Camille Mehlman, Paul Takam Kamga, Adrien Costantini, Catherine Julié, Coraline Dumenil, Jennifer Dumoulin, Julia Ouaknine, Violaine Giraud, Thierry Chinet, Jean François Emile, Etienne Giroux-Leprieur
Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer. Cancers 13 (5) (2021)
Adrien Costantini, Paul Takam Kamga, Catherine Julie, Alexandre Corjon, Coraline Dumenil, Jennifer Dumoulin, Julia Ouaknine, Violaine Giraud, Thierry Chinet, Martin Rottman, Jean François Emile, Etienne Giroux Leprieur
Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers 13 (1) (2020)
Paul Takam Kamga, Giada Dal Collo, Adriana Cassaro, Riccardo Bazzoni, Pietro Delfino, Annalisa Adamo, Alice Bonato, Carmine Carbone, Riccardo Bazzoni, Massimiliano Bonifacio, Mauro Krampera
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia. Cancers 12 (9) (2020)
Luisa Tomasello, Marzia Vezzalini, Christian Boni, Massimiliano Bonifacio, Luigi Scaffidi, Mohamad A Yassin, Nader Al Dewik, Paul Takam Kamga, Mauro Krampera, Claudio Sorio
Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia. International journal of molecular sciences 21 (7) (2020)
Paul Takam Kamga, Giada Dal Collo, Federica Resci, Riccardo Bazzoni, Angela Mercuri, Francesca Maria Quaglia, Ilaria Tanasi, Pietro Delfino, Carlo Visco, Massimiliano Bonifacio, Mauro Krampera
Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia. Cancers 11 (12) (2019)
Adrien Costantini, Paul Takam Kamga, Coraline Dumenil, Thierry Chinet, Jean François Emile, Etienne Giroux Leprieur
Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection? Cancers 11 (9) (2019)
Paul Takam Kamga, Giada Dal Collo, Martina Midolo, Annalisa Adamo, Pietro Delfino, Angela Mercuri, Simone Cesaro, Elda Mimiola, Massimiliano Bonifacio, Angelo Andreini, Marco Chilosi, Mauro Krampera
Inhibition of Notch Signaling Enhances Chemosensitivity in B-cell Precursor Acute Lymphoblastic Leukemia. Cancer research 79 (3) (2018)

Paul Takam Kamga.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Paul Takam Kamga